NCT01877785View on ClinicalTrials.gov

A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Healthy Volunteer

Interventions

DRUG

MHAA4549A

Single-ascending dose of MHAA4549A

DRUG

Placebo

Placebo to MHAA4549A

Trial Locations (1)

G1P 0A2

Québec

Sponsors

Lead Sponsor

Genentech, Inc.

All Listed Sponsors

lead

Genentech, Inc.

INDUSTRY

NCT01877785 - A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers | Biotech Hunter | Biotech Hunter